Cognitive effects of cell-derived and synthetically derived Aβ oligomers

Miranda N. Reed, Jacki J Hofmeister, Lisa Jungbauer, Alfred T. Welzel, Chunjiang Yu, Mathew A Sherman, Sylvain E Lesne, Mary Jo LaDu, Dominic M. Walsh, Karen H Ashe, James P. Cleary

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Soluble forms of amyloid-β peptide (Aβ) are a molecular focus in Alzheimer's disease research. Soluble Aβ dimers (≈8. kDa), trimers (≈12. kDa), tetramers (≈16. kDa) and Aβ*56 (≈56. kDa) have shown biological activity. These Aβ molecules have been derived from diverse sources, including chemical synthesis, transfected cells, and mouse and human brain, leading to uncertainty about toxicity and potency. Herein, synthetic Aβ peptide-derived oligomers, cell- and brain-derived low-n oligomers, and Aβ*56, were injected intracerebroventricularly (icv) into rats assayed under the Alternating Lever Cyclic Ratio (ALCR) cognitive assay. Cognitive deficits were detected at 1.3 μM of synthetic Aβ oligomers and at low nanomolar concentrations of cell-secreted Aβ oligomers. Trimers, from transgenic mouse brain (Tg2576), did not cause cognitive impairment at any dose tested, whereas Aβ*56 induced concentration-dependent cognitive impairment at 0.9 and 1.3 μM. Thus, while multiple forms of Aβ have cognition impairing activity, there are significant differences in effective concentration and potency.

Original languageEnglish (US)
Pages (from-to)1784-1794
Number of pages11
JournalNeurobiology of Aging
Volume32
Issue number10
DOIs
StatePublished - Oct 1 2011

Fingerprint

Brain
Amyloid
Cognition
Transgenic Mice
Uncertainty
Alzheimer Disease
Peptides
Research
Cognitive Dysfunction
peptide A

Keywords

  • Alzheimer's disease
  • Amyloid-β peptide
  • Cognition
  • Oligomers

Cite this

Reed, M. N., Hofmeister, J. J., Jungbauer, L., Welzel, A. T., Yu, C., Sherman, M. A., ... Cleary, J. P. (2011). Cognitive effects of cell-derived and synthetically derived Aβ oligomers. Neurobiology of Aging, 32(10), 1784-1794. https://doi.org/10.1016/j.neurobiolaging.2009.11.007

Cognitive effects of cell-derived and synthetically derived Aβ oligomers. / Reed, Miranda N.; Hofmeister, Jacki J; Jungbauer, Lisa; Welzel, Alfred T.; Yu, Chunjiang; Sherman, Mathew A; Lesne, Sylvain E; LaDu, Mary Jo; Walsh, Dominic M.; Ashe, Karen H; Cleary, James P.

In: Neurobiology of Aging, Vol. 32, No. 10, 01.10.2011, p. 1784-1794.

Research output: Contribution to journalArticle

Reed, MN, Hofmeister, JJ, Jungbauer, L, Welzel, AT, Yu, C, Sherman, MA, Lesne, SE, LaDu, MJ, Walsh, DM, Ashe, KH & Cleary, JP 2011, 'Cognitive effects of cell-derived and synthetically derived Aβ oligomers', Neurobiology of Aging, vol. 32, no. 10, pp. 1784-1794. https://doi.org/10.1016/j.neurobiolaging.2009.11.007
Reed, Miranda N. ; Hofmeister, Jacki J ; Jungbauer, Lisa ; Welzel, Alfred T. ; Yu, Chunjiang ; Sherman, Mathew A ; Lesne, Sylvain E ; LaDu, Mary Jo ; Walsh, Dominic M. ; Ashe, Karen H ; Cleary, James P. / Cognitive effects of cell-derived and synthetically derived Aβ oligomers. In: Neurobiology of Aging. 2011 ; Vol. 32, No. 10. pp. 1784-1794.
@article{cae05325a55641f096696e947fdba37c,
title = "Cognitive effects of cell-derived and synthetically derived Aβ oligomers",
abstract = "Soluble forms of amyloid-β peptide (Aβ) are a molecular focus in Alzheimer's disease research. Soluble Aβ dimers (≈8. kDa), trimers (≈12. kDa), tetramers (≈16. kDa) and Aβ*56 (≈56. kDa) have shown biological activity. These Aβ molecules have been derived from diverse sources, including chemical synthesis, transfected cells, and mouse and human brain, leading to uncertainty about toxicity and potency. Herein, synthetic Aβ peptide-derived oligomers, cell- and brain-derived low-n oligomers, and Aβ*56, were injected intracerebroventricularly (icv) into rats assayed under the Alternating Lever Cyclic Ratio (ALCR) cognitive assay. Cognitive deficits were detected at 1.3 μM of synthetic Aβ oligomers and at low nanomolar concentrations of cell-secreted Aβ oligomers. Trimers, from transgenic mouse brain (Tg2576), did not cause cognitive impairment at any dose tested, whereas Aβ*56 induced concentration-dependent cognitive impairment at 0.9 and 1.3 μM. Thus, while multiple forms of Aβ have cognition impairing activity, there are significant differences in effective concentration and potency.",
keywords = "Alzheimer's disease, Amyloid-β peptide, Aβ, Cognition, Oligomers",
author = "Reed, {Miranda N.} and Hofmeister, {Jacki J} and Lisa Jungbauer and Welzel, {Alfred T.} and Chunjiang Yu and Sherman, {Mathew A} and Lesne, {Sylvain E} and LaDu, {Mary Jo} and Walsh, {Dominic M.} and Ashe, {Karen H} and Cleary, {James P.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1016/j.neurobiolaging.2009.11.007",
language = "English (US)",
volume = "32",
pages = "1784--1794",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Cognitive effects of cell-derived and synthetically derived Aβ oligomers

AU - Reed, Miranda N.

AU - Hofmeister, Jacki J

AU - Jungbauer, Lisa

AU - Welzel, Alfred T.

AU - Yu, Chunjiang

AU - Sherman, Mathew A

AU - Lesne, Sylvain E

AU - LaDu, Mary Jo

AU - Walsh, Dominic M.

AU - Ashe, Karen H

AU - Cleary, James P.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Soluble forms of amyloid-β peptide (Aβ) are a molecular focus in Alzheimer's disease research. Soluble Aβ dimers (≈8. kDa), trimers (≈12. kDa), tetramers (≈16. kDa) and Aβ*56 (≈56. kDa) have shown biological activity. These Aβ molecules have been derived from diverse sources, including chemical synthesis, transfected cells, and mouse and human brain, leading to uncertainty about toxicity and potency. Herein, synthetic Aβ peptide-derived oligomers, cell- and brain-derived low-n oligomers, and Aβ*56, were injected intracerebroventricularly (icv) into rats assayed under the Alternating Lever Cyclic Ratio (ALCR) cognitive assay. Cognitive deficits were detected at 1.3 μM of synthetic Aβ oligomers and at low nanomolar concentrations of cell-secreted Aβ oligomers. Trimers, from transgenic mouse brain (Tg2576), did not cause cognitive impairment at any dose tested, whereas Aβ*56 induced concentration-dependent cognitive impairment at 0.9 and 1.3 μM. Thus, while multiple forms of Aβ have cognition impairing activity, there are significant differences in effective concentration and potency.

AB - Soluble forms of amyloid-β peptide (Aβ) are a molecular focus in Alzheimer's disease research. Soluble Aβ dimers (≈8. kDa), trimers (≈12. kDa), tetramers (≈16. kDa) and Aβ*56 (≈56. kDa) have shown biological activity. These Aβ molecules have been derived from diverse sources, including chemical synthesis, transfected cells, and mouse and human brain, leading to uncertainty about toxicity and potency. Herein, synthetic Aβ peptide-derived oligomers, cell- and brain-derived low-n oligomers, and Aβ*56, were injected intracerebroventricularly (icv) into rats assayed under the Alternating Lever Cyclic Ratio (ALCR) cognitive assay. Cognitive deficits were detected at 1.3 μM of synthetic Aβ oligomers and at low nanomolar concentrations of cell-secreted Aβ oligomers. Trimers, from transgenic mouse brain (Tg2576), did not cause cognitive impairment at any dose tested, whereas Aβ*56 induced concentration-dependent cognitive impairment at 0.9 and 1.3 μM. Thus, while multiple forms of Aβ have cognition impairing activity, there are significant differences in effective concentration and potency.

KW - Alzheimer's disease

KW - Amyloid-β peptide

KW - Aβ

KW - Cognition

KW - Oligomers

UR - http://www.scopus.com/inward/record.url?scp=80051665699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051665699&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2009.11.007

DO - 10.1016/j.neurobiolaging.2009.11.007

M3 - Article

C2 - 20031278

AN - SCOPUS:80051665699

VL - 32

SP - 1784

EP - 1794

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 10

ER -